Nasdaq CM: RVPH Reviva Virtual KOL Event on Brilaroxazine (RP5063) in Phase 3 Clinical Trials for Schizophrenia Watch Replay Overview Press Releases Events & Presentations Events Corporate Presentation Stock Data Stock Quote & Chart Analyst Coverage Financials & Filings SEC Filings Quarterly Results Governance Documents & Charters Committee Composition Shareholder Resources Email Alerts FAQs FAQs
